Fevipiprant
目录号: A17244
CRTh2 receptor 拮抗剂
Fevipiprant,也被称为 NVP-QAW039 或 QAW039,是一种口服活性且高效的 CRTh2 受体拮抗剂,可能对哮喘治疗有益。
Discription | Fevipiprant, also known as NVP-QAW039 or QAW039, is an oral active and potent CRTh2 receptor antagonist and potentially useful for asthma treatment. | ||
---|---|---|---|
Targets |
|
目录号 | A17244 |
---|---|
分子式 | C19H17F3N2O4S |
分子量 | 426.4102 |
CAS号 | 872365-14-5 |
SMILES | O=C(O)CC1=C(C)N(CC2=CC=C(S(=O)(C)=O)C=C2C(F)(F)F)C3=NC=CC=C31 |
其他名称 | NVP-QAW039; NVP-QAW 039; NVP-QAW-039 QAW-039; QAW039; QAW 039; |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2